Genus (LON:GNS) Stock Price Crosses Above 200 Day Moving Average of $4,662.17

Share on StockTwits

Shares of Genus plc (LON:GNS) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 4,662.17 ($60.91) and traded as high as GBX 5,190 ($67.81). Genus shares last traded at GBX 4,972 ($64.96), with a volume of 83,400 shares trading hands.

Separately, Liberum Capital boosted their price objective on shares of Genus from GBX 4,490 ($58.66) to GBX 4,760 ($62.19) and gave the company a “buy” rating in a research report on Monday, January 18th.

The firm has a market cap of £3.25 billion and a price-to-earnings ratio of 67.55. The stock’s 50 day moving average is GBX 5,076.46 and its 200 day moving average is GBX 4,662.17. The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 28.59.

The business also recently declared a dividend, which was paid on Thursday, April 1st. Investors of record on Thursday, March 4th were paid a GBX 10.30 ($0.13) dividend. The ex-dividend date of this dividend was Thursday, March 4th. This represents a yield of 2.06%. Genus’s dividend payout ratio (DPR) is currently 0.40%.

In other Genus news, insider Iain Ferguson bought 500 shares of Genus stock in a transaction on Thursday, February 25th. The shares were purchased at an average price of GBX 4,851 ($63.38) per share, with a total value of £24,255 ($31,689.31). In the last ninety days, insiders acquired 1,003 shares of company stock worth $4,840,680.

About Genus (LON:GNS)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Story: How are the companies in the S&P 500 selected?

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with's FREE daily email newsletter.